VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
The global oral clinical nutrition supplement market is entering a phase of sustained, evidence-backed growth as healthcare ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果